Key facts
| Price (PPV) | 155.80 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | amlodipineirbesartan |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09CA04 |
| Manufacturer | SANOFI AVENTIS MAROC |
| Presentation | Boite de 28 |
| Nature | Médicament |
| Hospital price | 97.40 MAD |
| Data collected on | 9/8/2026 |
Indications
APROVASC® est indiqué chez l’adulte dans le traitement de l’hypertension artérielle insuffisamment contrôlée par irbésartan ou amlodipine en monothérapie.
Find an open pharmacy
On-call pharmacies near you
About Aprovasc 150 mg / 5mg
Aprovasc 150 mg / 5mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by SANOFI AVENTIS MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Aprovasc 150 mg / 5mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Aprovasc 150 mg / 5mg
Answers to common questions from Moroccan patients about this drug.